The FDA has approved Boehringer Ingelheim's nerandomilast as a treatment for idiopathic pulmonary fibrosis (IPF), giving the company a successor to its blockbuster therapy Ofev. Phosphodiesterase (PDE ...

PETALING JAYA: Analysts remain “overweight” on the glove sector, stating the sector stocks are trading at deep value levels. In a report to clients, Kenanga Research said despite the lack of near-term ...